Trade Names: | |
Synonyms: | |
Status: | Approved (2017) |
Entry Type: | Antibody |
Molecule Category: | UNKNOWN |
ATC: | L01XC31 |
UNII: | KXG2PJ551I |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Neoplasms | 4 | D009369 | ClinicalTrials |
Carcinoma, Renal Cell | 3 | D002292 | ClinicalTrials |
Carcinoma, Squamous Cell | 3 | D002294 | ClinicalTrials |
Lymphoma, Large B-Cell, Diffuse | 3 | D016403 | ClinicalTrials |
Carcinoma, Squamous Cell | 3 | D002294 | ClinicalTrials |
Colonic Neoplasms | 3 | D003110 | ClinicalTrials |
Carcinoma, Renal Cell | 3 | D002292 | ClinicalTrials |
Urogenital Neoplasms | 3 | D014565 | ClinicalTrials |
Stomach Neoplasms | 3 | D013274 | ClinicalTrials |
Breast Neoplasms | 3 | D001943 | ClinicalTrials |
Carcinoma, Non-Small-Cell Lung | 3 | D002289 | ClinicalTrials |
Breast Neoplasms | 3 | D001943 | ClinicalTrials |
Breast Neoplasms | 3 | D001943 | ClinicalTrials |
Ovarian Neoplasms | 3 | D010051 | ClinicalTrials |
Leiomyosarcoma | 2 | D007890 | ClinicalTrials |
Small Cell Lung Carcinoma | 2 | D055752 | ClinicalTrials |
Multiple Myeloma | 2 | D009101 | ClinicalTrials |
Hemangiosarcoma | 2 | D006394 | ClinicalTrials |
Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
Esophageal Neoplasms | 2 | D004938 | ClinicalTrials |
Urinary Bladder Neoplasms | 2 | D001749 | ClinicalTrials |
Thymoma | 2 | D013945 | ClinicalTrials |
Hodgkin Disease | 2 | D006689 | ClinicalTrials |
Carcinoma, Adenoid Cystic | 2 | D003528 | ClinicalTrials |
Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
Thymoma | 2 | D013945 | ClinicalTrials |
Neuroendocrine Tumors | 2 | D018358 | ClinicalTrials |
Urinary Bladder Neoplasms | 2 | D001749 | ClinicalTrials |
Carcinoma, Hepatocellular | 2 | D006528 | ClinicalTrials |
Carcinoma, Neuroendocrine | 2 | D018278 | ClinicalTrials |
Glioblastoma | 2 | D005909 | ClinicalTrials |
Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
Endometrial Neoplasms | 2 | D016889 | ClinicalTrials |
Adenocarcinoma | 2 | D000230 | ClinicalTrials |
Urinary Bladder Neoplasms | 2 | D001749 | ClinicalTrials |
Lymphoma | 2 | D008223 | ClinicalTrials |
Osteosarcoma | 2 | D012516 | ClinicalTrials |
Pancreatic Neoplasms | 2 | D010190 | ClinicalTrials |
Rectal Neoplasms | 2 | D012004 | ClinicalTrials |
Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
Nasopharyngeal Neoplasms | 2 | D009303 | ClinicalTrials |
Gestational Trophoblastic Disease | 2 | D031901 | ClinicalTrials |
Skin Neoplasms | 1 | D012878 | ClinicalTrials |
Lymphoma, Follicular | 1 | D008224 | ClinicalTrials |
Leukemia, Myeloid, Acute | 1 | D015470 | ClinicalTrials |
Mesothelioma | 1 | D008654 | ClinicalTrials |
Melanoma | 1 | D008545 | ClinicalTrials |
Meningioma | 1 | D008579 | ClinicalTrials |
Prostatic Neoplasms | 1 | D011471 | ClinicalTrials |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | D015464 | ClinicalTrials |
Head and Neck Neoplasms | 1 | D006258 | ClinicalTrials |
Chordoma | 1 | D002817 | ClinicalTrials |
Lymphoma, Non-Hodgkin | 1 | D008228 | ClinicalTrials |
Peritoneal Neoplasms | 1 | D010534 | ClinicalTrials |
Fallopian Tube Neoplasms | 1 | D005185 | ClinicalTrials |
Lymphoma, Follicular | 1 | D008224 | ClinicalTrials |
Glioma | 1 | D005910 | ClinicalTrials |
Carcinoma, Pancreatic Ductal | 0 | D021441 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 1537032-82-8 |
ChEMBL | CHEMBL3833373 |
FDA SRS | KXG2PJ551I |
Guide to Pharmacology | 8735 |